Biocardia Inc
(BCDA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,623 | -9,162 | -6,456 | -2,969 | -15,004 |
| Depreciation Amortization | 60 | 45 | 30 | 149 | 68 |
| Accounts receivable | 85 | 34 | 3 | 42 | -85 |
| Other Working Capital | -63 | 71 | 604 | 521 | 133 |
| Other Operating Activity | 2,175 | 1,621 | 1,071 | 374 | 2,531 |
| Operating Cash Flow | $-10,366 | $-7,391 | $-4,748 | $-1,883 | $-12,357 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -116 | -75 | -55 | -27 | -32 |
| Investing Cash Flow | $-116 | $-75 | $-55 | $-27 | $-32 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 506 |
| Common Stock Issued | 2,006 | 1,947 | 2,006 | 2,005 | 27,865 |
| Other Financing Activity | -59 | 0 | -67 | 0 | -160 |
| Financing Cash Flow | $1,947 | $1,947 | $1,939 | $2,005 | $28,211 |
| Beginning Cash Position | 21,407 | 21,407 | 21,407 | 21,407 | 5,585 |
| End Cash Position | 12,872 | 15,888 | 18,543 | 21,502 | 21,407 |
| Net Cash Flow | $-8,535 | $-5,519 | $-2,864 | $95 | $15,822 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,366 | -7,391 | -4,748 | -1,883 | -12,357 |
| Capital Expenditure | -116 | -75 | -55 | -27 | -32 |
| Free Cash Flow | -10,482 | -7,466 | -4,803 | -1,910 | -12,389 |